C10011514 / invoice 10000

Patient Discharge:Findings:Abdominal ultrasound revealed 7 cm length of affected small intestine with additional 1-2 cm affected areaGastric wall thickening present, diffuse rather than discrete massModerate enlargement of gut-associated lymph nodesSplenic involvement with over 30 small nodules measuring up to 3 mm diameter and several moderate-sized nodules up to 2 cmKidney, adrenal, pancreas, gallbladder, urinary bladder, and large intestine appeared normalNo free abdominal fluid detectedBlood test organised to assess anaemia progression and iron statusNew lymphoma blood test included given ultrasound findings consistent with possible lymphoma presentationPrognosis:PoorDischarge Instructions:Prednisolone commenced today as anti-inflammatory and potential anti-neoplastic therapyMonitor for increased appetite, thirst, and urination frequencyMay require more frequent outdoor access due to increased urinationDosing flexibility available with current mid-range dose allowing adjustment up or down based on responseAim for lowest effective dose that maintains comfortConsider easily digestible diet to reduce gastrointestinal workloadMonitor bowel movements and watch for nauseaBlood results will determine if iron supplementation required via initial intramuscular injection followed by specific oral preparationsMeds:Prednisolone 5mg (0.8mg/kg) once daily, with option to increase to twice daily if neededImportant: Do not discontinue prednisolone suddenly if used long-term - gradual withdrawal essentialOwner expressed understanding of findings and treatment planDiscussed genetic versus environmental factors in disease developmentOwner coping well with diagnosis on difficult day (male owner's birthday)Insurance claim to be processed for medications    Vital Signs